Management of pyoderma gangrenosum: An update on clinical features, diagnosis and therapy;Management des pyoderma gangraenosum : Update zu klinik, diagnose und therapie

Hautarzt

Volumn 61, Issue 4, 2010, Pages 345-355

  Tremezaygues L ^a   Schmaltz, R ^a   Vogt, T ^a   Reichrath, J ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Immunosuppression; Neutrophil granulocytes; Pyoderma gangrenosum; Ulcers

Indexed keywords

IMMUNOGLOBULIN M;

ALLERGIC REACTION; AUTOIMMUNE SKIN DISEASE; AUTOTRANSPLANTATION; CLINICAL ASSESSMENT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; ENTERITIS; EXCISION; HISTOPATHOLOGY; HUMAN; IMMUNE COMPLEX DISEASE; IMMUNOCOMPROMISED PATIENT; IMMUNOFLUORESCENCE MICROSCOPY; LABORATORY TEST; MYELOPROLIFERATIVE DISORDER; PATHOGENESIS; PYODERMA GANGRENOSUM; REMISSION; REVIEW; SKIN GRAFT; SKIN INFLAMMATION; SKIN NECROSIS; SKIN PAIN; SKIN ULCER; WOUND HEALING;

ADULT; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PYODERMA GANGRENOSUM;

EID: 77952682042     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-009-1909-8     Document Type: Review

References (48)

1. Bennett ML, Jackson JM, Jorizzo JL et al (2000) Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions. Medicine (Baltimore) 79:37-46
2. Neal M, Blitz DPM, Rudikoff MD (2001) Pyoderma gangrenosum. Mount Sinai J Med 68:287297
3. Brunsting LA, Goeckerman WH, OLeary PA (1930) Pyoderma gangrenosum: clinical and experimental observation in five cases occurring in adults. Arch Dermatol 22:655
4. Münter KC (o J) Das Pyoderma gangraenosum - eine multidisziplinäre Herausforderung. Wundzentrum Hamburg.
5. Altmeyer P, Holzmann H, Bacharach-Buhles M, Buhles N (1986) Lexikon der Dermatologie. Springer, Berlin Heidelberg New York
6. Hasselmann DO, Bens G, Tilgen W, Reichrath J (2007) Pyoderma gangrenosum: clinical presentation and outcome in 18 cases and review of the literature. JDDG 5:560564
7. Cairns BA, Herbst CA, Sartor BR et al (1994) Peristomal pyoderma gangrenosum and inflammatory bowel disease. Arch Surg 129(7):769772
8. Perry HO, Brunsting LA (1957) Pyoderma gangrenosum: a clinical study of 19 cases. Arch Dermatol 75:380386
9. Fritsch P (1983) Dermatologie. Springer, Berlin Heidelberg New York
10. Regueiro M, Valentine J, Plevy S et al (2003) Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease. Am J Gastroenterol 98:18211826
11. Romero-Gomez M, Sanchez-Munoz D (2002) Infliximab induces remission of pyoderma gangrenosum. Eur J Gastroenterol Hepatol 14:907
12. Brooklyn TN, Dunnill M, Shetty A et al (2006) Infliximab for the treatment of pyoderma gangrenosum: a randomized, double-blind, placebo controlled trial. Gut 55:505509
13. Reguiai Z, Grange F (2007) The role of anti-tumor necrosis factor-alpha therapy in pyoderma gangraenosum associated with inflammatory bowel disease. Am J Clin Dermatol 8:6777
14. Kawakami T, Yamasaki M, Soma Y (2009) Reduction of Interleukin-6, Interleukin-8, and Anti-phosphatidylserine-prothrombin complex antibody by granulocyte and monocyte adsorption apheresis in a patient with pyoderma gangraenosum and ulcerative colitis. Am J Gastroenterol 104:23632364
15. Braun-Falco O (1984) Dermatologie und Venerologie. Springer, Berlin Heidelberg
16. Wines N, Wines M, Ryman W (2001) Understanding pyoderma gangrenosum: a review. MedGenMed 3(3):6
17. Tay CH (1973) Pyoderma gangrenosum and leukemia. Arch Dermatol 108:580
18. Jacobs P, Palmer S, Gordon-Smith ES (1985) Pyoderma gangrenosum in myelodysplasia and acute leukemia. Post-Grad Med J 61:689
19. Bundino S, Zina AM (1984) Pyoderma gangrenosum associated with selective hereditary IgA deficiency. Dermatologica 168:230
20. Crowson AN, Magro C, Mihm MC Jr (2003) Pyoderma gangrenosum: a review. J Cutan Pathol 30:97107
21. Powell FC, Schroeter AL, Su WPD, Perry HO (1984) Pyoderma gangrenosum and sarcoidosis. Arch Dermatol 120:959
22. Schwartz BK, Clendenning WE, Blasik LG (1986) Pyoderma gangrenosum in a patient with HTLV-III antibody. Arch Dermatol 122:508
23. OLoughlin S, Perry HO (1978) A diffuse pustular eruption associated with ulcerative colitis. Arch Dermatol 114(7):10611064
24. Perry HO, Winkelmann RK (1972) Bullous pyoderma gangrenosum and leukemia. Arch Dermatol 106(6):901905
25. Wilson-Jones E, Winkelmann RK (1988) Superficial granulomatous pyoderma: a localized vegetative form of pyoderma gangrenosum. J Am Acad Dermatol 18(3):511521
26. Brown TS, Marshall GS, Callen JP (2000) Cavitating pulmonary Infiltrate in an adolescent with pyoderma gangrenosum: a rarely recognized extracutaneous manifestation of a neutrophilic dermatosis. J Am Acad Dermatol 43:108112
27. Miserocchi E, Modorati G, Foster CS, Brancato R (2002) Ocular and extracutaneous involvement in pyoderma gangrenosum. Ophthalmology 109:19411943
28. Reichrath J, Bens G, Bonowitz A, Tilgen W (2005) Treatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients. J Am Acad Dermatol 53(2):273283
29. Rose GE, Barnes EA, Uddin JM (2003) Pyoderma gangrenosum of the ocular adnexa: a rare condition with characteristic clinical appearances. Ophthalmology 110:801805
30. Setterfield JF, Shirlaw PJ, Challacombe SJ, Black MM (2001) Pyoderma gangrenosum associated with severe oropharyngeal involvement and IgA paraproteinaemia. Br J Dermatol 144:393396
31. Gonzalgo ML, Lacerda DA de, De Marzo AM, Chan DY (2003) Persistent purulent drainage from the glans penis: atypical presentation of pyoderma gangrenosum. J Urol 169:17931794
32. Von den Driesch P (1997) Pyoderma gangrenosum: a report of 44 cases with follow-up. Br J Dermatol 137(6):10001005
33. Su WP, Davis MD, Weenig RH et al (2004) Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria. Int J Dermatol 43(11):790800
34. Mlika RB, Riahi I, Fenniche S et al (2002) Pyoderma gangrenosum: a report of 21 cases. Int J Dermatol 41:6568
35. Chow RK, Ho VC (1996) Treatment of pyoderma gangrenosum. J Am Acad Dermatol 34:10471060
36. Matis WL, Ellis CN, Griffiths CE, Lazarus GS (1992) Treatment of pyoderma gangrenosum with cyclosporine. Arch Dermatol 128:10601064
37. Moraes M, Russo G (2001) Thalidomide and its dermatologic uses. Am J Med Sci 321:321326
38. Wollina U, Karamfilov T (2000) Treatment of recalcitrant ulcers in pyoderma gangrenosum with mycophenolate mofetil and autologous keratinocyte transplantation on a hyaluronic acid matrix. J Eur Acad Dermatol Venereol 14:187190
39. Abu-Elmagd K, Jegasothy BV, Ackerman CD et al (1991) Efficacy of FK 506 in the treatment of recalcitrant pyoderma gangrenosum. Transplant Proc 23:33283329
40. Abu-Elmagd K, Van Thiel DH, Jegasothy BV et al (1993) Resolution of severe pyoderma gangrenosum in a patient with streaking leukocyte factor disease after treatment with tacrolimus (FK 506). Ann Intern Med 119:595598
41. Dobson CM, Parslew RA, Evans S (2003) Superficial granulomatous pyoderma treated with intravenous immunoglobulin. J Am Acad Dermatol 48:456460
42. Gerard A, Schooneman F, Voiriot P et al (1988) Pyoderma gangrenosum: treatment with plasma exchange (4 cases). Ann Med Interne (Paris) 139(Suppl1):2931
43. Wenzel J, Gerdsen R, Phillipp-Dormston W et al (2002) Topical treatment of pyoderma gangrenosum. Dermatology 205:221223
44. Tsele E, Yu RC, Chu AC (1992) Pyoderma gangrenosum response to topical nitrogen mustard. Clin Exp Dermatol 17:437440
45. Sanders CJ, Hulsmans RF (1993) Successful treatment of pyoderma gangrenosum with topical 5-aminosalicylic acid. Cutis 51:262264
46. Vereecken P, Wautrecht JC, De Dobbeleer G, Heenen M (1997) A case of pyoderma gangrenosum stabilized with lymecycline, topical benzoyl peroxide and treated by autograft. Dermatology 195:5051
47. Kanekura T, Maruyama I, Kanzaki T (2002) Granulocyte and monocyte adsorption apheresis for pyoderma gangrenosum. J Am Acad Dermatol 47:320321
48. Smith JB, Shenefelt PD, Soto O, Valeriano J (1996) Pyoderma gangrenosum in a patient with cryoglobulinemia and hepatitis C successfully treated with interferon alfa. J Am Acad Dermatol 34:901903